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Respiratory infections are the main cause of morbidity and mortality in cystic
ﬁbrosis, and bacteria belonging to the Burkholderia cepacia complex (Bcc) are im-
portant infection agents. Bcc comprises nine species that are difﬁcult to distinguish
in routine clinical analysis. Nowadays a combination of molecular techniques is
required for a correct identiﬁcation of Bcc species; however, the application of these
methods in clinical routine presents some difﬁculties. The aim of this study was to
set up diagnostic methods based on SNuPE (Single Nucleotide Primer extension)
and LAMP (Loop-mediated isothermal ampliﬁcation). SNuPE allows detecting a
single nucleotide polymorphism on a DNA target and to reduce misinterpretaion
in Bcc species identiﬁcation. Besides, it requires less time than the combination of
techniques actually in use. LAMP is a very important tool in clinical ﬁelds since it
requires simple equipments available in all laboratories.
Fifty-six strains both from environmental and clinical source and representative of
nine BCC species were used.
We focused our attention on some genes of the histidine biosynthetic operon. Thus, a
3,500 bp DNA fragment from the 56 Bcc strains was PCR-ampliﬁed. The nucleotide
sequence of each fragment was then determined and analyzed. In this way seven
primers for the SNuPE technique were designed and used in multiplex reactions
for obtaining the SNuPE proﬁles from Bcc strains.
Moreover, a set of primers for the LAMP was designed and used to amplify a his
region of some Bcc reference strains.
Data obtained showed the high grade of applicability of both methods on Bcc
members identiﬁcation.
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Introduction and Aims: We have previously shown by culture that the lungs of
CF patients are colonised by both aerobic and anaerobic bacteria. The aim of this
study was to compare culture and culture-independent techniques for determining
the composition of bacterial communities in the sputum of CF patients.
Methods: Sputum was collected and processed using strict anaerobic techniques,
prior to commencing and at the end of antibiotic therapy, from 26 adult CF patients
admitted for treatment of an acute exacerbation. For culture detection, samples were
plated on selective agars and bacteria quantiﬁed by viable count and identiﬁed by
PCR and sequencing of 16S rRNA genes. For molecular detection, total DNA was
extracted from sputum and bacterial species were identiﬁed by terminal restriction
fragment length polymorphism analysis of PCR ampliﬁed 16S rRNA genes. Total
bacterial abundance was determined by quantitative PCR.
Results: There was a good correlation between culture and molecular detection
of the predominant aerobic pathogens (P. aeruginosa and B. cepacia complex).
Anaerobic bacteria, from the genera Prevotella and Veillonella, were detected by
both methods and were primarily associated with P. aeruginosa infection. Addi-
tional anaerobes were only identiﬁed by molecular detection. Bacterial community
composition varied between patients but remained constant within most individuals
before and after antibiotic treatment.
Conclusion:Molecular detection is both sensitive and accurate and may be a useful
diagnostic technique for assessing infection in CF.
161 Molecular detection of multiple emerging pathogens in sputa
from cystic ﬁbrosis patients
F. Bittar1, H. Richet1, J.C. Dubus2, M. Reynaud-Gaubert3, N. Stremler2,
J. Sarles2, D. Raoult1, J.M. Rolain1. 1URMITE UMR 6236, CNRS-IRD, Faculte´
de Me´decine et de Pharmacie, Marseille, France; 2De´partement des Maladies
Respiratoires, CRCM Enfants, Marseille, France; 3De´partement des Maladies
Respiratoires, CRCM Adultes, Marseille, France
There is strong evidence that culture-based methods detect only a small proportion
of bacteria in the respiratory tracts of cystic ﬁbrosis (CF) patients. Herein we have
compared standard microbiological culture to molecular methods by the use of 16S
rDNA ampliﬁcation, cloning and sequencing in a series of CF sputa. Our purposes
were to evaluate the bacterial diversity and to describe new pathogens colonizing
CF lung. Twenty-ﬁve sputa from CF patients were cultured that yield 33 isolates (14
species) known to be pathogens during CF. For molecular cloning, 760 clones were
sequenced, and 53 different bacterial species were identiﬁed including 16 species of
anaerobes (30%). The mean number of species per sputum was 7.2±3.9. Identical
results between culture and molecular data were observed in only 54.5% of cases.
Discrepancies were numerous and demonstrate that accurate identiﬁcation remains
challenging. New or emerging bacteria not or rarely reported in CF patients were
detected including Dolosigranulum pigrum, Dialister pneumosintes, and Inquilinus
limosus. Our results demonstrate the complex microbial community in CF sputum,
new or emerging bacteria may be detected in these patients, and anaerobes are
probably an underestimated cause of CF lung pathology. Metagenomic analysis is
urgently needed to better understand the complex communities in CF pulmonary
infections.
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Over the past decade, the bacteria present in the lungs of cystic ﬁbrosis (CF)
patients have been shown to be highly diverse. Although the composition of these
communities is increasingly well identiﬁed, very little is currently known about
community dynamics. Such information would be of potentially profound clinical
impact. The aim of this study was to determine the degree to which the bacterial
community varies in the lungs of individual CF patients over time. In this study,
the focus was on patients who were in clinically stable condition. A total of 15
sputa were collected from ﬁve CF patients over an average of 2 months. These
were analysed by using culture-independent Terminal Restriction Fragment Length
Polymorphism (T-RFLP) proﬁling of phylogenetically informative 16S rRNA genes
extracted and ampliﬁed from these samples. Preliminary analysis has shown that
the variation of the bacterial community in terms of the number and identity of
bacterial species differed by less than 5% with the dominant bacterial species being
conserved across samples taken from any one patient. The statistical signiﬁcance
of these ﬁndings in relation to the variation in abundance of the individual bacterial
species and the implications in relation to treatment are also discussed.
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